Progesterone in the Treatment of Acute Hemorrhagic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 184 participants.

Also called NCT04143880

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 184 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04143880
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04143880. Randomized; double masking; primary purpose treatment. Start 2020-02-01 (anticipated); primary completion 2020-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Progesterone in the Treatment of Acute Hemorrhagic Stroke
Condition
Stroke
Intervention (Drug)
Progesterone
Intervention (Other)
saline
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)
Collaborator
Korea University Anam Hospital (class: other)
Collaborator
Seoul National University Hospital (class: other)
Collaborator
Lishui Country People's Hospital (class: other)
Collaborator
Jinhua Central Hospital (class: other)
Collaborator
Huzhou Central Hospital (class: other)
Collaborator
The Affiliated Hospital of Hangzhou Normal University (class: other)

Record details

Record id
cardio:ct-nct04143880
Content hash
e6ebcd5f8c4a7519918e3cecb933430bd4e6131e27d5643b766117a5b3aaeba8